These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 350630)

  • 1. Vasoactive intestinal peptide stimulates pancreatic somatostatin release.
    Ipp E; Dobbs RE; Unger RH
    FEBS Lett; 1978 Jun; 90(1):76-8. PubMed ID: 350630
    [No Abstract]   [Full Text] [Related]  

  • 2. Somatostatin action on insulin secretion induced by chicken and porcine vasoactive intestinal peptide in the perfused rat pancreas.
    Arilla E; Prieto JC; López-Martínez JM; Goberna R
    Horm Metab Res; 1981 Jun; 13(6):314-7. PubMed ID: 6114916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Secretion of insulin and of glucagon by the perfused pancreas of newborn rats: effect of vasoactive intestinal peptide Vip].
    Vauclin N; Gespach C; Bataille D; Jarrousse C; Rosselin G
    C R Acad Hebd Seances Acad Sci D; 1977 Mar; 284(13):1207-10. PubMed ID: 406070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of insulin and glucagon secretion by vasoactive intestinal peptide.
    Schebalin M; Said SI; Makhlouf GM
    Am J Physiol; 1977 Feb; 232(2):E197-200. PubMed ID: 320878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut hormones and the alpha cell.
    Bloom SR; Iversen J
    Metabolism; 1976 Nov; 25(11 Suppl 1):1457-8. PubMed ID: 790093
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of intrapancreatic administration of vasoactive intestinal peptide upon the release of insulin and glucagon in dogs.
    Ohneda A; Ishii S; Horigome K; Chiba M; Sakai T; Kai Y; Watanabe K; Yamagata S
    Horm Metab Res; 1977 Nov; 9(6):447-52. PubMed ID: 590919
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of substance P and other peptides on the release of somatostatin, insulin, and glucagon in vitro.
    Hermansen K
    Endocrinology; 1980 Jul; 107(1):256-61. PubMed ID: 6155261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of vasoactive intestinal peptide (VIP) with cholinergic stimulation of glucagon secretion.
    Ahrén B; Lundquist I
    Experientia; 1982 Mar; 38(3):405-6. PubMed ID: 7042382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of gastrointestinal hormones (peptides) on insulin secretion: physiology or pharmacology?].
    Souquet JC; Riou JP; Chayvialle JA
    Journ Annu Diabetol Hotel Dieu; 1983; ():35-44. PubMed ID: 6196509
    [No Abstract]   [Full Text] [Related]  

  • 10. Isolation and characterization of a 60-residue intestinal peptide structurally related to the pancreatic secretory type of trypsin inhibitor: influence on insulin secretion.
    Agerberth B; Söderling-Barros J; Jörnvall H; Chen ZW; Ostenson CG; Efendić S; Mutt V
    Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8590-4. PubMed ID: 2573065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin secretion by isolated islets of Langerhans. Effects of pancreatic and intestinal hormones].
    Malaisse W; Malaisse-Lagae F
    Acta Diabetol Lat; 1968 Oct; 5 Suppl 1():64-76. PubMed ID: 4907227
    [No Abstract]   [Full Text] [Related]  

  • 12. Vasoactive intestinal peptide inhibits release of somatostatin from hypothalamus in vitro.
    Epelbaum J; Tapia-Arancibia L; Besson J; Rotsztejn WH; Kordon C
    Eur J Pharmacol; 1979 Oct; 58(4):493-5. PubMed ID: 510382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural regulation of pancreatic hormone secretion.
    Holst JJ
    Clin Physiol; 1985; 5 Suppl 5():34-42. PubMed ID: 2870834
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of neurotensin on insulin, glucagon, and somatostatin release from isolated pancreatic islets.
    Dolais-Kitabgi J; Kitabgi P; Brazeau P; Freychet P
    Endocrinology; 1979 Jul; 105(1):256-60. PubMed ID: 376297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A potent and highly selective VPAC2 agonist enhances glucose-induced insulin release and glucose disposal: a potential therapy for type 2 diabetes.
    Tsutsumi M; Claus TH; Liang Y; Li Y; Yang L; Zhu J; Dela Cruz F; Peng X; Chen H; Yung SL; Hamren S; Livingston JN; Pan CQ
    Diabetes; 2002 May; 51(5):1453-60. PubMed ID: 11978642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin and insulin release from isolated rat pancreatic islets stimulated by glucose.
    Schauder P; McIntosh C; Arends J; Arnold R; Frerichs H; Creutzfeldt W
    FEBS Lett; 1976 Oct; 68(2):225-7. PubMed ID: 789115
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings: Effect of gastrointestinal hormones on the phasic release on insulin from isolated islets of normal and obese hyperglycaemic mice.
    Best L; Atkins TW; Matty AJ
    J Endocrinol; 1975 Jun; 65(3):57P-58P. PubMed ID: 1097566
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of fasting on the release of insulin and somatostatin from perifused islets of Langerhans.
    Schauder P; McIntosh C; Arends J; Frerichs H
    Diabetes; 1979 Mar; 28(3):204-7. PubMed ID: 376377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic secretory trypsin inhibitor (PSTI) isolated from pig intestine. Influence on insulin and somatostatin release.
    Agerberth B; Ostenson CG; Efendic S; Jörnvall H
    FEBS Lett; 1991 Apr; 281(1-2):227-30. PubMed ID: 1673102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic AMP and gastrointestinal hormones. Studies in isolated pancreatic islets.
    Schatz H; Hinz M; Maier V; Nierle C; Pfeiffer EF
    Acta Endocrinol Suppl (Copenh); 1973; 173():125. PubMed ID: 4353556
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.